Westchester Capital Management (New York)’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-280,900
| Closed | -$2.88M | – | 353 |
|
|
2023
Q2 | $2.88M | Hold |
280,900
| – | – | 0.09% | 169 |
|
|
2023
Q1 | $2.84M | Hold |
280,900
| – | – | 0.09% | 211 |
|
|
2022
Q4 | $2.78M | Buy |
280,900
+115,000
| +69% | +$1.14M | 0.08% | 246 |
|
|
2022
Q3 | $1.61M | Hold |
165,900
| – | – | 0.05% | 296 |
|
|
2022
Q2 | $1.61M | Hold |
165,900
| – | – | 0.04% | 249 |
|
|
2022
Q1 | $1.62M | Buy |
+165,900
| New | +$1.62M | 0.04% | 241 |
|